Radiation boosts immunotherapy in advanced lung cancer trial
NCT ID NCT03176173
First seen Nov 05, 2025 · Last updated May 22, 2026 · Updated 21 times
Summary
This study tested whether adding high-dose, precisely targeted radiation to standard immunotherapy could help control advanced non-small cell lung cancer that has spread. Forty-five adults with stage IV disease who were already on immunotherapy received radiation to some tumors. The main goal was to see if this combination could slow cancer growth or shrink tumors. While not a cure, the approach aims to improve disease control and response to treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford University, School of Medicine
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.